Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Jun 14;8(6):e021174.
doi: 10.1136/bmjopen-2017-021174.

Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries

Affiliations
Randomized Controlled Trial

Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries

Chris Degeling et al. BMJ Open. .

Abstract

Objective: To elicit informed views from Australian women aged 70-74 regarding the acceptability of ceasing to invite women their age to participate in government-funded mammography screening (BreastScreen).

Design: Two community juries held in 2017.

Setting: Greater Sydney, a metropolis of 4.5 million people in New South Wales, Australia.

Participants: 34 women aged 70-74 with no personal history of breast cancer, recruited by random digit dialling and previously randomly recruited list-based samples.

Main outcomes and measures: Jury verdict and rationale in response to structured questions. We transcribed audio-recorded jury proceedings and identified central reasons for the jury's decision.

Results: The women's average age was 71.5 years. Participants were of diverse sociocultural backgrounds, with the sample designed to include women of lower levels of educational attainment. Both juries concluded by majority verdict (16-2 and 10-6) that BreastScreen should continue to send invitations and promote screening to their age group. Reasons given for the majority position include: (1) sending the invitations shows that society still cares about older women, empowers them to access preventive health services and recognises increasing and varied life expectancy; (2) screening provides women with information that enables choice and (3) if experts cannot agree, the conservative approach is to maintain the status quo until the evidence is clear. Reasons for the minority position were the potential for harms through overdiagnosis and misallocation of scarce health resources.

Conclusions: Preventive programmes such as mammography screening are likely to have significant symbolic value once they are socially embedded. Arguments for programme de-implementation emphasising declining benefit because of limited life expectancy and the risks of overdiagnosis seem unlikely to resonate with healthy older women. In situations where there is no consensus among experts on the value of established screening programmes, people may strongly prefer receiving information about their health and having the opportunity make their own choices.

Keywords: deliberative methods; health policy; mammography screening; overdiagnosis; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
The charge/question for the jury.

References

    1. Feig SA. Screening mammography benefit controversies: sorting the evidence. Radiol Clin North Am 2014;52:455–80. 10.1016/j.rcl.2014.02.009 - DOI - PubMed
    1. Walter LC, Schonberg MA. Screening mammography in older women: a review. JAMA 2014;311:1336–47. 10.1001/jama.2014.2834 - DOI - PMC - PubMed
    1. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000;92:550–6. 10.1093/jnci/92.7.550 - DOI - PubMed
    1. van de Water W, Markopoulos C, van de Velde CJ, et al. . Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 2012;307:590–7. 10.1001/jama.2012.84 - DOI - PubMed
    1. Bell RJ, Burton RC. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--no. Med J Aust 2012;196:17. - PubMed

Publication types

LinkOut - more resources